Compare DE & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DE | ABT |
|---|---|---|
| Founded | 1837 | 1888 |
| Country | United States | United States |
| Employees | 73100 | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.1B | 183.3B |
| IPO Year | 1994 | 2006 |
| Metric | DE | ABT |
|---|---|---|
| Price | $566.02 | $104.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 16 |
| Target Price | ★ $618.11 | $139.38 |
| AVG Volume (30 Days) | 1.1M | ★ 6.9M |
| Earning Date | 05-14-2026 | 04-16-2026 |
| Dividend Yield | 1.11% | ★ 2.41% |
| EPS Growth | ★ N/A | N/A |
| EPS | 2.42 | ★ 3.72 |
| Revenue | ★ $45,684,000,000.00 | $44,328,000,000.00 |
| Revenue This Year | N/A | $8.90 |
| Revenue Next Year | $9.88 | $7.39 |
| P/E Ratio | $240.07 | ★ $28.10 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $404.42 | $102.41 |
| 52 Week High | $674.19 | $137.49 |
| Indicator | DE | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 42.74 | 32.67 |
| Support Level | $457.94 | N/A |
| Resistance Level | $674.19 | $112.81 |
| Average True Range (ATR) | 14.06 | 2.11 |
| MACD | -2.81 | -0.44 |
| Stochastic Oscillator | 27.14 | 17.88 |
Deere is the world's leading manufacturer of agricultural equipment and a major producer of construction machinery. The company is divided into four reporting segments: production & precision agriculture, or PPA, small agriculture & turf, or SAT, construction & forestry, or CF, and financial services, or FS, its captive finance subsidiary. The core PPA business is the largest contributor to sales and profits by far. Geographically, Deere sales are 60% US/Canada, 17% Europe, 14% Latin America, and 9% rest of the world. Deere goes to market through a robust dealer network that includes over 2,000 dealer locations in North America with reach into over 100 countries. John Deere Financial provides retail financing for machinery to its customers and wholesale financing for dealers.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.